Gilteritinib Fumarate

Records for this ingredient, by country (identity only).

ATC L01EX13 · 3 markets · 3 records

Gilteritinib Fumarate 3 markets · 3 records Forms

Filters

MarketAU 1 SG 1 FR 1

Strength

AU 1 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

44.2 mgtabletXOSPATA gilteritinib (as fumarate) 40 mg film-coated tablet blister pack unknown

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

40 mgtabletXospata also in FR

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

40 mgtabletXOSPATA 40 mg, comprimé pelliculé also in SG

Side-by-side table

Strength / form / release	AU	SG	FR
40 mg tablet	not recorded	Xospata	XOSPATA 40 mg, comprimé pelliculé
44.2 mg tablet	XOSPATA gilteritinib (as fumarate) 40 mg film-coated tablet blister pack	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.